Molecular biologist C. David Allis investigates the histone code and its impact on gene regulation and chromosome dynamics.

Developmental biologist Kathryn Anderson studies genetic pathways that direct embryonic patterning and morphogenesis in the mouse embryo.

Chemical biologist Daniel Bachovchin designs selective inhibitors to study enzymes and pathways in cancer and immune system signaling.

Developmental biologist Zhirong Bao investigates how the genome dictates development using C. elegans as a model.

Developmental biologist Mary Baylies studies the mechanisms that form and maintain muscle both during normal development and in disease.

Epidemiologist Colin Begg focuses on statistical methods for cancer epidemiology, health services research, and clinical trials.

Cancer biologist Robert Benezra studies the molecular mechanisms of tumor growth and metastatic progression using mouse models. In addition, he studies the spindle assembly checkpoint which ensures proper chromosome segregation and is often deregulated in cancer.

Developmental biologist Peter Besmer focuses on normal and oncogenic receptor tyrosine kinase signaling in vitro and in vivo in mice.

Physician-scientist Ronald Blasberg focuses on the development of noninvasive imaging paradigms in living organisms using radionuclide and optical reporter systems.

Clinician-scientist Michelle Bradbury develops translational, tumor-targeting, PET-optical silica nanoparticle probes for diagnostics, drug delivery, and sensing.